Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Medullary × aldesleukin × Clear all

Sponsor

Conditions

Melanoma 46 Neoplasm Metastasis 19 Skin Neoplasms 14 Carcinoma, Renal Cell 13 Leukemia, Myeloid, Acute 11 Kidney Neoplasms 10 Leukemia 9 Neoplasms 7 Uterine Cervical Neoplasms 5 Lymphoma 5 Congenital Abnormalities 5 Breast Neoplasms 5 Ovarian Neoplasms 4 Neuroblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Vaginal Neoplasms 2 Penile Neoplasms 2 Papillomavirus Infections 2 Oropharyngeal Neoplasms 2 Melanoma, Experimental 2 Lymphoma, Mantle-Cell 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Brain Neoplasms 2

Interventions

vandetanib 9 cabozantinib 4 selpercatinib 3 Sunitinib 2 Sorafenib 2 yeast-CEA vaccine 1 tanespimycin 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 lenvatinib 1 Vorinostat 1 Temozolomide 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Irinotecan 1 Gefitinib 1 Ferrosoferric Oxide 1 Capecitabine 1 Bortezomib 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡